Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury

Abstract To understand the characteristic of changes of serum metabolites between healthy people and patients with hepatitis B virus (HBV) infection at different stages of disease, and to provide reference metabolomics information for clinical diagnosis of liver disease patients. 255 patients with d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cade4ab836244dad83fb55c0b7f9aa8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cade4ab836244dad83fb55c0b7f9aa8f
record_format dspace
spelling oai:doaj.org-article:cade4ab836244dad83fb55c0b7f9aa8f2021-12-02T15:56:49ZClinical significance of small molecule metabolites in the blood of patients with different types of liver injury10.1038/s41598-021-91164-92045-2322https://doaj.org/article/cade4ab836244dad83fb55c0b7f9aa8f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91164-9https://doaj.org/toc/2045-2322Abstract To understand the characteristic of changes of serum metabolites between healthy people and patients with hepatitis B virus (HBV) infection at different stages of disease, and to provide reference metabolomics information for clinical diagnosis of liver disease patients. 255 patients with different stages of HBV infection were selected. 3 mL blood was collected from each patient in the morning to detect differences in serum lysophosphatidylcholine, acetyl-l-carnitine, oleic acid amide, and glycocholic acid concentrations by UFLC-IT-TOF/MS. The diagnostic values of four metabolic substances were evaluated by receiver operating characteristic (ROC) curve. The results showed that the optimal cut-off value of oleic acid amide concentration of the liver cirrhosis and HCC groups was 23.6 mg/L, with a diagnostic sensitivity of 88.9% and specificity of 70.6%. The diagnostic efficacies of the three substances were similar in the hepatitis and HCC groups, with an optimal cut-off value of 2.04 mg/L, and a diagnostic sensitivity and specificity of 100% and 47.2%, respectively. The optimal cut-off value of lecithin of the HBV-carrier and HCC groups was 132.85 mg/L, with a diagnostic sensitivity and specificity of 88.9% and 66.7%, respectively. The optimal cut-off value of oleic acid amide of the healthy and HCC groups was 129.03 mg/L, with a diagnostic sensitivity and specificity of 88.4% and 83.3%, respectively. Lysophosphatidylcholine, acetyl-l-carnitine, and oleic acid amide were potential metabolic markers of HCC. Among them, lysophosphatidylcholine was low in the blood of HCC patients, and its diagnostic efficacy was better than that of acetyl-l-carnitine and oleic acid amide, providing reference metabolomics information in clinical diagnosis and future research.Hui LiYan WangShizhao MaChaoqun ZhangHua LiuDianxing SunNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hui Li
Yan Wang
Shizhao Ma
Chaoqun Zhang
Hua Liu
Dianxing Sun
Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
description Abstract To understand the characteristic of changes of serum metabolites between healthy people and patients with hepatitis B virus (HBV) infection at different stages of disease, and to provide reference metabolomics information for clinical diagnosis of liver disease patients. 255 patients with different stages of HBV infection were selected. 3 mL blood was collected from each patient in the morning to detect differences in serum lysophosphatidylcholine, acetyl-l-carnitine, oleic acid amide, and glycocholic acid concentrations by UFLC-IT-TOF/MS. The diagnostic values of four metabolic substances were evaluated by receiver operating characteristic (ROC) curve. The results showed that the optimal cut-off value of oleic acid amide concentration of the liver cirrhosis and HCC groups was 23.6 mg/L, with a diagnostic sensitivity of 88.9% and specificity of 70.6%. The diagnostic efficacies of the three substances were similar in the hepatitis and HCC groups, with an optimal cut-off value of 2.04 mg/L, and a diagnostic sensitivity and specificity of 100% and 47.2%, respectively. The optimal cut-off value of lecithin of the HBV-carrier and HCC groups was 132.85 mg/L, with a diagnostic sensitivity and specificity of 88.9% and 66.7%, respectively. The optimal cut-off value of oleic acid amide of the healthy and HCC groups was 129.03 mg/L, with a diagnostic sensitivity and specificity of 88.4% and 83.3%, respectively. Lysophosphatidylcholine, acetyl-l-carnitine, and oleic acid amide were potential metabolic markers of HCC. Among them, lysophosphatidylcholine was low in the blood of HCC patients, and its diagnostic efficacy was better than that of acetyl-l-carnitine and oleic acid amide, providing reference metabolomics information in clinical diagnosis and future research.
format article
author Hui Li
Yan Wang
Shizhao Ma
Chaoqun Zhang
Hua Liu
Dianxing Sun
author_facet Hui Li
Yan Wang
Shizhao Ma
Chaoqun Zhang
Hua Liu
Dianxing Sun
author_sort Hui Li
title Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
title_short Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
title_full Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
title_fullStr Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
title_full_unstemmed Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
title_sort clinical significance of small molecule metabolites in the blood of patients with different types of liver injury
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/cade4ab836244dad83fb55c0b7f9aa8f
work_keys_str_mv AT huili clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
AT yanwang clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
AT shizhaoma clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
AT chaoqunzhang clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
AT hualiu clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
AT dianxingsun clinicalsignificanceofsmallmoleculemetabolitesinthebloodofpatientswithdifferenttypesofliverinjury
_version_ 1718385419320557568